Innoviva appoints Derek Small to Board of Directors

Innoviva, Inc.

Derek Small appointed effective April 29, 2024; independent director.
Managing Director at Luson Bioventures; former CEO of Assembly Biosciences and Naurex.
Receives initial RSU award of $125,000, prorated RSU of $18,750, and options for 833 shares.
Annual cash retainer of $50,000; standard indemnification agreement with Innoviva.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Derek Small

Director

INVA · Innoviva, Inc.

Effective: 2024-04-29
Filed: April 30, 2024, 7:59 PM ET

On and effective as of April 29, 2024 (the “Small Effective Date”), Innoviva, Inc. (the “Company”) appointed Derek Small, to its Board of Directors (the “Board”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Derek Small was appointed as Director at Innoviva, Inc..

Action: appointed
Role: Director

Exact text from the filing

On and effective as of April 29, 2024 (the “Small Effective Date”), Innoviva, Inc. (the “Company”) appointed Derek Small, to its Board of Directors (the “Board”).

View on SEC.gov

Innoviva, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-123033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.